Alligator Bioscience AB
Records under this name other than the patents Alligator Bioscience AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 18 patents it holds.
Back to Alligator Bioscience AB
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,312,786 | Oncofetal Antigen Binding Proteins and Related Compositions and Methods Formerly held In force · High confidence | In force | High confidence | |
| US 9,834,589 | CD86 variants with improved affinity for CTLA-4 Lapsed on the fee record Ended Dec 5, 2025 · From the USPTO record | Lapsed on the fee record | Ended Dec 5, 2025 | From the USPTO record |
| US 11,008,396 | Novel Polypeptides Lapsed on the fee record Ended May 18, 2025 · High confidence | Lapsed on the fee record | Ended May 18, 2025 | High confidence |
| US 10,774,150 | Novel Polypeptides Lapsed on the fee record Ended Sep 15, 2024 · Medium confidence | Lapsed on the fee record | Ended Sep 15, 2024 | Medium confidence |
| US 8,685,640 | Medical methods and agents for use therein Lapsed on the fee record Ended Apr 1, 2022 · From the USPTO record | Lapsed on the fee record | Ended Apr 1, 2022 | From the USPTO record |
| US 7,282,334 | Method for in vitro molecular evolution of protein function Term ended Term ended Jan 7, 2021 · From the USPTO record | Term ended | Term ended Jan 7, 2021 | From the USPTO record |
| US 7,563,578 | Method for in vitro molecular evolution of protein function Term ended Ended no later than Dec 12, 2020 · From the USPTO record | Term ended | Ended no later than Dec 12, 2020 | From the USPTO record |
| US 9,486,520 | Compositions comprising polyglutamic acid nanoparticles and CD40 agonists Lapsed on the fee record Ended Nov 8, 2020 · From the USPTO record | Lapsed on the fee record | Ended Nov 8, 2020 | From the USPTO record |
| US 8,303,945 | Mutants of interleukin-1 receptor antagonist Lapsed on the fee record Ended Nov 6, 2020 · From the USPTO record | Lapsed on the fee record | Ended Nov 6, 2020 | From the USPTO record |
| US 6,495,321 | Method for in vitro molecular evolution of protein function Term ended Ended no later than Apr 6, 2020 · From the USPTO record | Term ended | Ended no later than Apr 6, 2020 | From the USPTO record |